| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,092 |
1,874 |
$97K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,374 |
1,307 |
$96K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,437 |
2,843 |
$90K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,989 |
1,345 |
$65K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
781 |
749 |
$42K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
814 |
658 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
906 |
771 |
$34K |
| 99000 |
|
3,887 |
3,163 |
$10K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
64 |
60 |
$5K |
| 99358 |
Prolong nursin fac eval 15m |
2,419 |
2,276 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
352 |
339 |
$5K |
| 94760 |
|
812 |
775 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
195 |
193 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
212 |
207 |
$1K |
| 81002 |
|
534 |
520 |
$868.17 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
89 |
83 |
$501.52 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
45 |
$322.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$74.80 |
| 81000 |
|
42 |
41 |
$61.92 |
| 99072 |
|
3,817 |
3,124 |
$0.00 |
| 99051 |
|
2,650 |
2,423 |
$0.00 |